Buy Aurobindo Pharma with a stoploss of Rs 124, says Siddhartha Chaterjee of Trustline Securities
Chaterjee told CNBC-TV18, "Recently Aurobindo Pharma has received an approval from the US health regulators to manufacture and market generic Gabapentin tablets while that could be the fundamental news. Buy Aurobindo Pharma with a stoploss of Rs 124 and target of Rs 131."Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
